
Maxorif 400mg Tablet
Marketer
Intra Life
Salt Composition
Rifaximin (400mg)
Overview Maxorif 400mg Tablet
Hepatic encephalopathy, a liver-related condition causing toxin buildup in the bloodstream and subsequent brain impairment, responds to treatment with the antibiotic Maxorif 400mg tablets. This medication also combats infectious diarrhea. Its mechanism involves eradicating and inhibiting the growth of harmful intestinal bacteria. Maxorif 400mg may be administered independently or alongside other medications, with or without food, ideally at a consistent time daily. Dosage and treatment duration should strictly adhere to the physician's instructions for optimal efficacy. Consistent daily intake is crucial; premature cessation can lead to infection recurrence and increased treatment difficulty. Potential side effects, including nausea, vomiting, headache, dizziness, skin rash, arthralgia, and depression, are generally transient, subsiding as the body adapts. Persistent or bothersome side effects warrant immediate medical consultation. A harmless, temporary reddish discoloration of urine is a possible consequence. Prior to commencing treatment, disclose any pregnancy, breastfeeding, liver, kidney, or heart conditions, or medication allergies to your doctor.
Uses of Maxorif 400mg Tablet
Managing hepatic encephalopathy and infectious diarrhea.
Major Benefits of Maxorif 400mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Maxorif 400mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Maxorif 400mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Ascites (accumulation of fluid in the abdominal cavity)
- Fatigue
- Depression
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Joint pain
- Rash
- Muscle pain
How to use Maxorif 400mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Maxorif 400mg tablets can be administered with or without food, although consistent timing is recommended.
How Maxorif 400mg Tablet works:
Ammoniagen, a 400mg antibiotic tablet, combats hepatic encephalopathy by eliminating ammonia-generating bacteria within the gastrointestinal system. This action alleviates infection symptoms (agitation, cognitive impairment, and myopathy) and diminishes the likelihood of future encephalopathy episodes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Maxorif 400mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Maxorif 400mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on available data, the use of 400mg Maxorif tablets while breastfeeding is likely safe. Studies in humans indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Maxorif 400mg tablets.
KidneySAFE IF PRESCRIBED
Maxorif 400mg tablets appear to pose minimal risk for individuals with impaired kidney function. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Maxorif 400mg tablets, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Maxorif 400mg Tablet :
Should you forget a Maxorif 400mg Tablet dose, take it immediately. However, near the time for your next dose, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Maxorif 400mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Rifamycin analogs |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | Rifamycin Antibiotics: RNA Polymerase Inhibitors |
